Bernstein Adjusts Price Target on Elevance Health to $585 From $511, Keeps Outperform Rating
(MT Newswires covers equity, commodity and economic research from major banks and research firms in
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
© 1999-2025 Midnight Trader, Inc. All rights reserved.

Related News
-
MT Newswires - 21 minutes ago
-
FDA Approves Sanofi's Hemophilia Drug
Benzinga - 22 minutes ago
-
JPMorgan Initiates Penguin Solutions at Neutral With $20 Price Target
MT Newswires - 22 minutes ago
-
Vizsla Silver Up in U.S. Pre-Market on New High-Grade Discovery at Panuco Project in Mexico
MT Newswires - 22 minutes ago
-
United receives FAA approval for first Starlink-equipped airplanes
Reuters - 24 minutes ago
-
CGI to Buy Apside, Launches CGI Advantage With Ventura County
MT Newswires - 25 minutes ago
-
Germany's DHL to acquire US pharma logistics firm Cryopdp
Reuters - 26 minutes ago
-
Jefferies Adjusts Oracle Price Target to $190 From $220, Maintains Buy Rating
MT Newswires - 27 minutes ago